SynthesisJournal of the American Heart Association2015
Transvenous Implantable Cardioverter-Defibrillator (ICD) Lead Performance: A Meta-Analysis of Observational Studies.
Synthesis in Journal of the American Heart Association, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Landscape of Cardiovascular Device Registries in the United States.Journal of the American Heart Association · 2019Pooled it
- Safety and Performance of INVICTA DF4 Ventricular Defibrillation Lead: Results From APOLLO Prospective Multicenter Study.Pacing and clinical electrophysiology : PACE · 2026Observational
- Lead replacement due to non-infectious reasons in patients with cardiac resynchronization therapy in long-term follow-up.ESC heart failure · 2026Article
- Mexican guidelines 2024 for the diagnosis and treatment of hypertrophic cardiomyopathy.Archivos de cardiologia de Mexico · 2024Article
- Impact of lead detecting algorithms on inappropriate shocks in implantable cardioverter defibrillator lead failure: a single-center manufacturer-independent observational study.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2023Observational
- Cardiovascular implantable electronic device lead safety: Harnessing real-world remote monitoring data for medical device evaluation.Heart rhythm · 2023Article
- Rationale and design of the Lead Evaluation for Defibrillation and Reliability study: Safety and efficacy of a novel ICD lead design.Journal of cardiovascular electrophysiology · 2023Article
- Early Experience with the Biotronik Protego ICD Lead.Journal of clinical medicine · 2022Article
- Prospective long-term follow-up of silicone-polyurethane-insulated implantable cardioverter-defibrillator leads.Heart rhythm O2 · 2022Article
- Impairment of Quality of Life in Patients with Implanted Subcutaneous Cardioverter Defibrillator (S-ICD) Compared to Implanted Transvenous Cardioverter Defibrillator Therapy.Patient preference and adherence · 2022Article
- Implantable Cardioverter-Defibrillator Lead in an Explanted Human Heart.Chonnam medical journal · 2022Article
- Cost-Effectiveness of Cardioverter-Defibrillator Implantation in Kazakhstan.Vascular health and risk management · 2022Article
- Occluded vein as a predictor for complications in non-infectious transvenous lead extraction.Frontiers in cardiovascular medicine · 2022Article
- Comparison of the performance of implantable cardioverter-defibrillator leads among manufacturers.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2020Article
- Article
- Article
- First time description of early lead failure of the Linox Smart lead compared to other contemporary high-voltage leads.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2018Article
- Implantable Cardioverter-defibrillators in Adult Congenital Heart Disease.The Journal of innovations in cardiac rhythm management · 2018Review
- Risk Factors and Temporal Trends of Complications Associated With Transvenous Implantable Cardiac Defibrillator Leads.Journal of the American Heart Association · 2018Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDespite the widespread use of implantable cardioverter-defibrillators (ICDs) in clinical practice, concerns exist regarding ICD lead durability. The performance of specific lead designs and factors determining this in large populations need clarification. METHODS AND
resultsThe Medline, Embase, and Cochrane Collaboration databases were searched for studies including ≥2 of the most commonly implanted leads. The Mantel-Haenszel random-effects model was used. Seventeen studies were selected, including a total of 49 871 patients-5538 implanted with Durata (St. Jude Medical Inc), 10 605 with Endotak Reliance (Boston Scientific), 16 119 with Sprint Quattro (Medtronic Corp), 11 709 with Sprint Fidelis (Medtronic Corp), and 5900 with Riata (St. Jude Medical Inc)-with follow-up of 136 509 lead-years. Although the Durata lead presented a numerically higher rate, no statistically significant differences in the mean incidence of lead failure (0.29%-0.45% per year) were observed in comparison of the 3 nonrecalled leads. A higher event rate was documented with the Riata (1.0% per-year increase) and Sprint Fidelis (>2.0% per-year increase) leads compared with nonrecalled leads. An indication of increased incidence of Durata lead failure versus Sprint Quattro and Endotak Reliance leads was observed in 1 of 3 included studies, allowing for comparison of purely electrical lead failure, but this requires further evaluation.
conclusionsEndotak Reliance (8F), Sprint Quattro (8F), and Durata (7F) leads displayed low annual incidence of failure; however, long-term follow-up data are still scarce. More data are needed to clarify the performance and safety of the Durata lead.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.